Link to EAHP Statements

• Section 1 - Introductory Statements and Governance: Statement - 1.5
• Section 2 - Selection, Procurement and Distribution: Statement - 2.6
• Section 3 - Production and Compounding: Statement - 3.2
• Section 6 - Education and Research: Statement - 6.5

ACPE UAN: 0475-0000-23-021-L04-P - A knowledge-based activity

Abstract

Many hospital pharmacists are involved in clinical trials with medicinal products in their hospital. If a pharmaceutical company is the sponsor of the trial, the role of the hospital pharmacist covers mostly the logistics, storage and reconstitution of the investigational medicinal product (IMP). These basic routines, if performed in clinical trials, come with additional tasks regarding the drug accountability, the traceability, or the blinding of the IMP.

If hospital pharmacists are involved early in the planning of academic clinical trials, their contribution goes far beyond the above-mentioned tasks. Some clinical questions require blinded administration of the drugs being evaluated to ensure an unbiased assessment of effect. Although this fact is recognised by experts in clinical trial methodology, the availability of blinded drugs can be difficult and may require some trade-offs, or may even result in the discontinuation of research projects.

Particularly in the academic setting, pharmacists can make important contributions in developing IMPs tailored to the research question and in determining the appropriate strategy for blinding and emergency unblinding. As specialists for the production of medicinal products, hospital pharmacists also compile the IMP-related documentation for the submission to the competent authorities.

This seminar will provide the basic knowledge to perform these additional tasks and give examples of successful interprofessional collaboration. Besides, it will give insight into the design and realisation of investigator initiated clinical trials (IICTs) in the hospital setting and the challenges investigators and pharmacists may face during planning and conducting clinical trials.

Learning objectives

After the session, the participant should be able to:

• Evaluate a clinical research project in terms of pharmaceutical requirements for the development and production of investigational medicinal products (intervention, comparator) in open or blinded manner
• Outline the key factors to be considered in organising the drug-related processes within a clinical trial
• Assess the different tasks and interprofessional interfaces in planning and conducting clinical trials (from the perspective of hospital pharmacists)

Educational need addressed

Hospital pharmacists need to know details regarding the design of investigator initiated trials with medicinal product and potential difficulties during the conduct of a clinical study in order to support the investigator with organising the medication related tasks.

Keywords: Clinical trial, randomisation, blinding, investigational medicinal product, manufacture